Question 1

Does Barclays own BBIO stock?

Accepted Answer

Yes. As of its Q3 2026 13F, Barclays holds 754,600 shares of BBIO (BridgeBio Pharma), worth $49.7M.

Question 2

How many shares of BBIO does Barclays own?

Accepted Answer

As of its Q3 2026 13F, Barclays holds 754,600 shares of BBIO (BridgeBio Pharma).

Question 3

What is Barclays' BBIO position worth?

Accepted Answer

As of its Q3 2026 13F, Barclays' BBIO position is worth $49.7M.

Question 4

Is Barclays buying or selling BBIO?

Accepted Answer

In Q3 2026, Barclays increased its BBIO position by 40,177 shares (+5.6%).

Question 5

When did Barclays first buy BBIO?

Accepted Answer

Barclays first reported BBIO in its Q2 2019 13F and has listed it in 30 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q3 Latest	Increased	754,600	+5.6%	$49.7M	0.0%	$65.80	31
2026-Q2	Increased	714,423	+68.5%	$53.2M	0.0%	$74.48	43
2026-Q1	Decreased	423,888	-31.9%	$31.5M	0.0%	$74.26	0
2025-Q4	Decreased	622,575	-13.5%	$47.6M	0.0%	$76.49	0
2025-Q3	Decreased	719,448	-22.9%	$37.4M	0.0%	$51.94	0
2025-Q2	Increased	933,512	+140.1%	$40.3M	0.0%	$43.18	47
2025-Q1	Decreased	388,838	-13.1%	$13.4M	0.0%	$34.57	0
2024-Q4	Decreased	447,510	-17.9%	$12.3M	0.0%	$27.44	0
2024-Q3	Increased	545,008	+31.9%	$13.9M	0.0%	$25.46	36